News
Columbia University, the Company’s collaboration partner for pre-clinical development, granted Silo an exclusive global license to further develop, manufacture, and commercialize SPC-15 worldwide.
PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on the research and commercialization of ketamine ...
Liam McArthur is a Liberal Democrat and therefore a fundamentally inoffensive chap. Owlish and earnest, firm but polite, he ...
Total Operating Expenses: Total operating expenses were $42.9 million for the first quarter of 2025, including research and development expenses of $29.1 million and general and administrative ...
THE right-to-die Bill’s mastermind last night said Holyrood took a “brave step” by backing it — but added: “It’s a step I believe Scotland is ready to take.” Lib Dem Liam McArthur gasped with ...
ATH-1105 is the Company's novel, orally available, brain-penetrant, next-generation small molecule drug candidate designed to ...
IDLProcycling on MSN1d
Sir Chris Hoy back on track with positive update after cancer battle: ‘Can’t believe where I’m at now’The cycling world was left reeling in February last year when track legend Sir Chris Hoy revealed he had been diagnosed with ...
A study published in JAMA Network Open found a potential link between proximity to golf courses and increased rates of the ...
One KISS fan has no regrets after paying Gene Simmons for the chance to act as his roadie for the day – at the cost of a cool ...
VANCOUVER, BC / ACCESS Newswire / May 13, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery ...
Once prostate cancer no longer responds to hormonal therapy, the cancer is called castration-resistant. Find out which ...
High blood pressure (hypertension) can be caused by a variety of factors, including your lifestyle, medical conditions, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results